Systemic glucocorticoid use and early-onset basal cell carcinoma

Jose Ramon Troche¹, Leah M Ferrucci², Brenda Cartmel², David J Leffell³, Allen E Bale⁴, Susan T Mayne⁵

Affiliations

¹ Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.
² Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT; Yale Cancer Center, New Haven, CT.
³ Yale Cancer Center, New Haven, CT; Departments of Dermatology and Surgery, Yale University School of Medicine, New Haven, CT.
⁴ Yale Cancer Center, New Haven, CT; Department of Genetics, Yale University School of Medicine, New Haven, CT.
⁵ Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT; Yale Cancer Center, New Haven, CT. Electronic address: susan.mayne@yale.edu.

PMID: 24958637
PMCID: PMC4119504
DOI: 10.1016/j.annepidem.2014.05.009

Systemic glucocorticoid use and early-onset basal cell carcinoma

Jose Ramon Troche et al. Ann Epidemiol. 2014 Aug.

. 2014 Aug;24(8):625-7.

doi: 10.1016/j.annepidem.2014.05.009. Epub 2014 May 22.

Authors

Jose Ramon Troche¹, Leah M Ferrucci², Brenda Cartmel², David J Leffell³, Allen E Bale⁴, Susan T Mayne⁵

Affiliations

¹ Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.
² Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT; Yale Cancer Center, New Haven, CT.
³ Yale Cancer Center, New Haven, CT; Departments of Dermatology and Surgery, Yale University School of Medicine, New Haven, CT.
⁴ Yale Cancer Center, New Haven, CT; Department of Genetics, Yale University School of Medicine, New Haven, CT.
⁵ Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT; Yale Cancer Center, New Haven, CT. Electronic address: susan.mayne@yale.edu.

PMID: 24958637
PMCID: PMC4119504
DOI: 10.1016/j.annepidem.2014.05.009

No abstract available

Keywords: Basal cell carcinoma; Case-control; Epidemiology; Glucocorticoids; Immunosuppressives; Keratinocyte carcinoma; Nonmelanoma skin cancer.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Nothing to declare.

Cited by

Skin Cancer Correlations in Psoriatic Patients.
Costache DO, Bejan H, Poenaru M, Costache RS. Costache DO, et al. Cancers (Basel). 2023 Apr 25;15(9):2451. doi: 10.3390/cancers15092451. Cancers (Basel). 2023. PMID: 37173917 Free PMC article. Review.

References

1. Zoorob RJ, Cender D. A different look at corticosteroids. Am Fam Physician. 1998 Aug;58(2):443–50. Epub 1998/08/26. - PubMed
1. Bangash HK, Colegio OR. Management of Non-Melanoma Skin Cancer in Immunocompromised Solid Organ Transplant Recipients. Curr Treat Options Oncol. 2012 May 17; Epub 2012/05/18. - PubMed
1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003 Apr 24;348(17):1681–91. Epub 2003/04/25. - PubMed
1. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation. 1990 Mar;49(3):506–9. Epub 1990/03/01. - PubMed
1. Hofbauer GF, Bouwes Bavinck JN, Euvrard S. Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol. 2010 Jun;19(6):473–82. Epub 2010/05/21. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Systemic glucocorticoid use and early-onset basal cell carcinoma

Affiliations

Systemic glucocorticoid use and early-onset basal cell carcinoma

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical